TECH

Nasdaq

BIO-TECHNE Corp

Health Care, Life Sciences Tools & Services

$72.29

close 7 Aug 2026

+44.15%

52-week change

$11.31B

market cap

$43.20

$72.37

52-week range

Expected price

$40.95 – $50.05

Current price

$72.29

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)104.77x

P/S (TTM)9.34x

P/B5.43x

EV/EBITDA (TTM)44.70x

FCF yield (TTM)2.38%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average74.30x

P/E, sector median29.65x*

Price at 5-year median P/E$45.13*

Indicated dividend yield0.44%

Forward — analyst consensus

Forward P/E (FY2026)37.68x*

Forward P/E (FY2027)35.37x

Forward PEG5.78*

Consensus EPS FY2026 (13 analysts)$1.92

EPS growth (FY2026→FY2027)6.52%

Revenue growth (FY2026)-0.92%

Street view

Price target (mean)$69.73*

Target upside-3.55%

Ratings (buy / hold / sell)2 / 12 / 0

FY2026 EPS revisions, 30d (up / down)0 / 1

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 31 Mar 2026, filed 6 May 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +10.82%10Y CAGR +7.94%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$72.29

Cash & equivalents$209.82M

Total debt$200.00M

Shares outstanding156.52M

Result

DCF price per share$61.51

Current price$72.29

Margin of safety-14.92%

PV of years 1–10$3.12B

PV of terminal value$6.50B

Equity value$9.63B

Market-implied growth+12.91%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$298.77M	$331.10M	$366.92M	$406.62M	$450.62M	$499.38M	$553.41M	$613.29M	$679.65M	$753.18M	$14.04B
PV	$276.64M	$283.86M	$291.27M	$298.88M	$306.68M	$314.69M	$322.91M	$331.34M	$339.99M	$348.87M	$6.50B

period to 31 Mar 2026, filed 6 May 2026, close 7 Aug 2026